LINC00336 and neoplasm: The injection of A549-LINC00336 and SPC-A-1-LINC00336 showed that LINC00336 overexpression significantly increased tumor sizes, volumes, and weights after 1 month of growth compared with A549-Vector and SPC-A-1-Vector cells (Fig. 2g–l), whereas the whole-body weight remained unchanged (Supplementary Fig. 2c, d).